Edition:
United Kingdom

Selexis Expands Strategic Immuno-Oncology Alliance With Agenus


Wednesday, 9 Jan 2019 

Jan 9 (Reuters) - Selexis SA::SELEXIS EXPANDS STRATEGIC IMMUNO-ONCOLOGY ALLIANCE WITH AGENUS.SELEXIS SA SAYS HAS SIGNED ADDITIONAL COMMERCIAL LICENSE AGREEMENTS WITH AGENUS.SELEXIS SA SAYS UNDER NEW LICENSE AGREEMENTS, AGENUS WILL LEVERAGE SELEXIS' MODULAR SURETECHNOLOGY PLATFORM FOR PRODUCTION OF ITS THERAPEUTIC PROTEINS. 

Company Quote

2.53
-0.01 -0.39%
18 Apr 2019